Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%
- Check15 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedAdded results posting status, EU CTIS number, and updated revision; introduced explicit PFS/OS calculations with new time windows (PFS up to 32 months, OS up to 58 months) replacing prior values.SummaryDifference5%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as additional resources related to cancer and renal cell carcinoma. Notably, the previous version's specific location details have been largely replaced or removed.SummaryDifference18%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.